Singapore Research Funding Landscape

Singapore’s public research funding runs through three separate systems that a researcher or research administrator new to the country needs to tell apart before scoping any project: the National Research Foundation (NRF), which sets national research strategy and funds cross-cutting strategic programmes; the Agency for Science, Technology and Research (A*STAR), which performs and funds mission-oriented research through its own institutes; and the Ministry of Education’s Academic Research Fund (AcRF), which funds investigator-led academic research at Singapore’s universities. A fourth system — the Ministry of Health’s National Medical Research Council (NMRC) — funds health and biomedical research specifically. None of these bodies is a simple substitute for another; each funds a different kind of research through a different process, and a single principal investigator can hold awards from more than one at the same time.

This page is an orientation map, not a scheme-by-scheme manual. CASRAI already has dedicated, detailed guides to NRF and A*STAR (linked throughout), so this page deliberately does not re-explain their eligibility rules or application mechanics. Its own contribution is twofold: it lays out how the three-and-more systems relate to each other administratively, and it covers the MOE Academic Research Fund — the one major piece of Singapore’s funding landscape that does not yet have its own dedicated CASRAI page — in real depth.

The short version: three funders, three different jobs

NRF sits inside the Prime Minister’s Office and does not itself perform research. It sets Singapore’s national Research, Innovation and Enterprise (RIE) strategy and directly funds the strategic, cross-institutional programmes designed to work across universities, A*STAR, and industry at once — fellowships, investigatorships, large multi-disciplinary programmes, and the RIE Flagships/Grand Challenges layered on top of each five-year RIE plan.
A*STAR is a statutory board under the Ministry of Trade and Industry. It both performs and funds mission-oriented, often industry-linked research through its own network of research institutes (organized under its Biomedical Research Council and Science and Engineering Research Council), and it runs its own scholarship and fellowship programmes to build that institute-based research workforce.
MOE’s Academic Research Fund (AcRF) funds investigator-initiated, curiosity-driven academic research based at Singapore’s universities themselves, administered through a tiered structure described below. This is the route most comparable to a “standard” competitive academic research grant in other national systems.
NMRC, under the Ministry of Health, funds health and biomedical research specifically, including work based in Singapore’s public healthcare clusters and medical schools — a sector-specific parallel to the three general bodies above.

The practical question for a researcher scoping a Singapore-based project or collaboration is rarely “does Singapore fund this kind of work” — it almost always does, somewhere in this system. The real question is which of these bodies funds it, because that determines the application route, the review process, and who administers the award.

NRF: national strategy and cross-cutting programmes

NRF does not compete with universities or A*STAR institutes for the same research dollar; it operates one level up, setting the national RIE plan (currently RIE2030, a five-year, S$37 billion plan covering April 2026 through 2030) and funding the programmes explicitly designed to cut across institutions — the NRF Fellowship, NRF Investigatorship, Competitive Research Programme, Corporate Laboratories, CREATE, and the RIE Flagships and Grand Challenges. For the full picture of NRF’s governance, its funding pillars, and how the RIE plan cycle works, see CASRAI’s NRF Singapore funding overview; for NRF’s flagship early-career award specifically, see the NRF Fellowship guide.

A*STAR: mission-oriented research performed in-house

A*STAR is structurally distinct from NRF — a statutory board under the Ministry of Trade and Industry rather than a Prime Minister’s Office department — and its funding character is different too. Where NRF funds work performed elsewhere, A*STAR performs a large share of its own funded research directly, through its network of institutes at Biopolis (biomedical sciences) and Fusionopolis (physical sciences and engineering), and it funds external, largely industry-linked and collaborative research through mechanisms like the Industry Alignment Fund. It also runs its own scholarship and postdoctoral fellowship tracks to build the researcher pipeline for that institute network. See CASRAI’s A*STAR funding and scholarships overview for the current programmes, and the A*STAR International Fellowship guide for its postdoctoral fellowship in detail.

MOE Academic Research Fund (AcRF): investigator-led university research

The Academic Research Fund is the mechanism through which Singapore’s universities receive competitive funding for curiosity-driven, investigator-initiated academic research — the category of work that, in most other national systems, is funded through a general research council rather than a ministry of education. AcRF supports research at Singapore’s Autonomous Universities (the public universities that include the National University of Singapore, Nanyang Technological University, Singapore Management University, the Singapore University of Technology and Design, and the Singapore Institute of Technology) that has genuine academic significance and the potential to generate new knowledge of value to the wider academic community, rather than being tied to a specific national priority domain the way many NRF and A*STAR programmes are.

AcRF is organized into three tiers, distinguished by project scale and by how each tier is administered:

Tier 1 funds smaller individual or small-team projects — commonly cited total project values from roughly S$5,000 up to S$200,000 over a project term of around three years, with a lower ceiling applied to proposals in the Accountancy, Business, Humanities and Social Sciences discipline cluster. Tier 1 awards are typically administered internally by each university under a block allocation from MOE, rather than through a single centrally judged national competition — meaning the specific process and internal deadlines vary by institution.
Tier 2 funds larger, typically multi-investigator projects on a genuinely national competitive basis — commonly cited total project values from roughly S$500,000 up to S$1 million over about three years, again with a separate, lower entry threshold for the Accountancy, Business, Humanities and Social Sciences cluster. Tier 2 calls run on a recurring cycle (commonly referenced as twice yearly), reviewed and awarded at the national, cross-university level rather than by an individual institution alone.
Tier 3 is programme-level funding for high-impact, multi-disciplinary research carried out at scale — intended to bring together collaborative teams to pursue integrated solutions to larger scientific questions, rather than funding a single investigator-led project.

Figures and thresholds above are drawn from university research-office descriptions of current AcRF calls rather than independently re-derived; project-value ceilings, discipline-cluster carve-outs, and call cadence are periodically revised, so a research administrator should confirm the live thresholds and current call dates directly with the applicant’s home university research office or MOE before budgeting a proposal. Applications for AcRF, like several other Singapore national schemes, are managed through Singapore’s shared national grant portal — the same Integrated Grant Management System (IGMS) that NRF uses for its own schemes — which is itself a sign of how tightly the national grants infrastructure is shared across agencies even where the funding decisions themselves are not.

The practical distinction for a research administrator: AcRF is the route for investigator-led, discipline-driven academic research based at a university, evaluated primarily on academic merit and knowledge contribution. NRF’s schemes are the route for strategic, cross-cutting, or larger-scale programmes tied to national RIE priorities. A*STAR is the route for research performed within its own institutes, or external collaboration explicitly linked to A*STAR’s institute network. A single PI at NUS or NTU can hold an AcRF grant and an NRF award (an Investigatorship, say, or a CRP allocation) concurrently, because the two are evaluated through different processes against different criteria.

Other funders in the ecosystem

Beyond the three general-purpose systems above, several sector-specific and industry-facing bodies also fund research in Singapore and are worth knowing by name even where they fall outside this page’s scope:

National Medical Research Council (NMRC), under the Ministry of Health, has funded medical and health research in Singapore since 1994 — competitive individual and collaborative research grants, national research programmes, and health-research training fellowships, concentrated in the public healthcare clusters and Singapore’s medical schools. A biomedical or clinical project based in a hospital or medical school setting is more likely to route through NMRC than through NRF, A*STAR, or AcRF alone.
Economic Development Board (EDB) partners with NRF and A*STAR on the more industry- and investment-facing elements of national RIE programmes, including some RIE Flagships, rather than running a separate standing academic grant scheme of its own.
Other ministries and statutory boards — the National Environment Agency and others — fund research within their own sector remits on a smaller, more targeted scale.

How the RIE plan threads the system together

What keeps this from being four or five unrelated funding streams is Singapore’s national Research, Innovation and Enterprise (RIE) plan, a five-year strategic and budget cycle set by NRF with Cabinet approval. The current cycle, RIE2030, runs from April 2026 through 2030 with a S$37 billion committed budget across foundational research, innovation and enterprise, four priority domains carried over from the previous RIE2025 cycle, “white space” funding for programmes that emerge mid-cycle, and talent development, plus dedicated funding for cross-agency RIE Flagships and Grand Challenges. NRF’s own strategic schemes are the most direct implementing mechanism for the RIE plan, but A*STAR’s institute priorities, and to a lesser extent AcRF’s discipline-cluster balance and NMRC’s programme priorities, are all set with the same national plan as backdrop — which is why RIE plan boundaries matter even to a researcher who will never apply to NRF directly. For the full detail on RIE2025/RIE2030 budgets, priority domains, and governance, see the NRF Singapore funding overview.

Choosing the right route: questions to ask before you apply

For a researcher or research administrator scoping a Singapore-based project, working through these questions in order is a reasonable way to identify which system actually applies:

Is this investigator-led academic research based at a university, evaluated mainly on academic merit? Start with MOE’s AcRF (Tier 1 for smaller projects administered by the home institution, Tier 2 for larger nationally competitive projects, Tier 3 for large multi-disciplinary programmes).
Is this strategic, large-scale, or explicitly designed to cut across institutions or sectors, and tied to a national RIE priority? Look at NRF’s schemes — Investigatorship, Competitive Research Programme, Corporate Laboratories, CREATE, or an active RIE Flagship/Grand Challenge — or, for an early-career independent-investigator award specifically, the NRF Fellowship.
Is the work performed within, or in direct partnership with, an A*STAR research institute, or is it industry-linked collaborative research? Look at A*STAR’s own funding programmes, including the Industry Alignment Fund and its thematic calls.
Is the research health- or biomedical-focused and based in a hospital, healthcare cluster, or medical school? NMRC is the more likely primary route, alongside or instead of the general bodies above.
Does the project genuinely span more than one of these categories? That is common, not exceptional, in Singapore’s system — a large translational biomedical programme, for example, might combine an A*STAR institute, university-based investigators funded partly through AcRF, and NRF-level strategic funding under an RIE Flagship. Confirming which agency is the actual lead funder — not just which university or institute is involved — is a standard first step in scoping any Singapore collaboration.

Administrative overlaps worth knowing about

Singapore’s research-funding agencies are structurally distinct but deliberately interlinked, in ways that show up in day-to-day grants administration:

Shared portal infrastructure. NRF’s schemes and MOE’s AcRF Tier 2 calls are both administered through Singapore’s national Integrated Grant Management System (IGMS), reducing the number of separate application systems a researcher working across agencies has to learn.
Cross-representation in governance. A*STAR’s Chairman sits on the NRF Board, and the NRF Board itself spans ministerial members across National Development, Education, Health, Finance, and other portfolios plus the presidents of NUS and NTU — a structure built to keep national strategy, institute-based performance, and university-based research aligned rather than siloed.
Overlapping host and eligibility structures. A*STAR is itself one of the eight eligible host institutions for the NRF Fellowship, and a PI can simultaneously hold AcRF funding (university-administered) and NRF funding (nationally administered) for different pieces of their research programme, since the two are evaluated through separate competitions against separate criteria.

For a research administrator, the operational implication is that “which agency funds this” and “which institution the researcher is based at” are two separate questions in Singapore’s system, more often than in a country with a single dominant national funding council — confirming the funding agency explicitly, rather than assuming it from the host institution alone, is worth doing early in any Singapore-based proposal.

Frequently asked questions

What is the difference between NRF, A*STAR, and MOE’s Academic Research Fund?
NRF sets national research strategy and funds cross-cutting, strategic programmes from within the Prime Minister’s Office. A*STAR is a statutory board under the Ministry of Trade and Industry that performs and funds mission-oriented research through its own institutes. MOE’s Academic Research Fund (AcRF) funds investigator-led, curiosity-driven academic research based at Singapore’s universities. They are separate systems with separate application routes, and a single researcher can hold funding from more than one at once.

Which Singapore agency should I apply to for a university-based research project?
If the work is investigator-initiated academic research evaluated mainly on academic merit, MOE’s Academic Research Fund (AcRF) is usually the starting point. If it is strategic, large-scale, or tied to a national RIE priority domain, NRF’s schemes are more likely to apply. Health and biomedical research based in a hospital or medical school setting more often routes through NMRC.

What are the AcRF tiers?
AcRF is organized into three tiers. Tier 1 funds smaller projects (commonly cited at roughly S$5,000 to S$200,000 over about three years), typically administered internally by the home university. Tier 2 funds larger, multi-investigator projects (commonly cited at roughly S$500,000 to S$1 million over about three years) through a national competitive process. Tier 3 funds large, multi-disciplinary, programme-level research. Confirm current thresholds directly with the applicant’s university research office, since figures are periodically revised.

Can a researcher hold funding from more than one Singapore agency at the same time?
Yes. Because NRF, A*STAR, MOE’s AcRF, and NMRC fund different categories of research through different competitive processes, a single principal investigator can hold, for example, an AcRF grant and an NRF Investigatorship or Competitive Research Programme allocation concurrently.

Does Singapore have a single national research council, like the UK’s UKRI or the US’s NSF?
No single body plays that consolidated role. NRF comes closest to a coordinating, strategy-setting function, comparable in that respect to bodies like UKRI or France’s ANR, but A*STAR, MOE, and NMRC each retain their own independent funding remit and administrative process rather than operating under NRF.

Related CASRAI resources

Sources: National Research Foundation, Singapore (nrf.gov.sg); Ministry of Education, Singapore (moe.gov.sg) and university research-office descriptions of current AcRF calls; Ministry of Health, Singapore (moh.gov.sg) and National Medical Research Council (nmrc.gov.sg). AcRF project-value thresholds and call cadence reflect what was published at time of writing and are periodically revised — confirm current figures directly with the applicant’s university research office or MOE before relying on them for a live proposal.